Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-004307-20Phase 4Terminated
Phase 4, randomised, double-blind trial in postoperative pain comparing Articaine infusion, Bupivacaine infusion and Placebo infusion (3 arms). Primary endpoint: Oxycodone consumption in first 72 hours. Started Feb 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-004307-20.